Contract biopharmaceutical development and manufacturing with FDA-regulated GMP operations
Rentschler Biopharma is a CDMO (contract development and manufacturing organization) operating under strict FDA and GMP compliance across sites in Germany and the US. The tech stack reflects the regulatory and operational intensity of the business: SAP for enterprise resource planning, Azure cloud infrastructure for data pipelines, LIMS and analytical instruments (HPLC, FT-IR) for quality control, and emerging focus on data science and ETL modernization. The project roadmap—automation, QbD implementation, LIMS expansion, information security management—signals a company balancing legacy GMP documentation with digital transformation.
Notable leadership hires: Plant Engineering Team Lead, Batch Record Review Lead, Technical Operations Lead
Rentschler Biopharma develops and manufactures biopharmaceutical drugs on contract for clients ranging from preclinical research through commercial scale. The company supports multiple modalities (mammalian cell-based biologics, formulations, cell line development) and provided manufacturing support for approximately 25% of FDA-approved biologics in 2023 alone. Headquartered in Laupheim, Germany, with a US site in Milford, MA, the company employs roughly 1,400 people. Operations are organized around manufacturing and engineering, with emerging data science and process analytics roles reflecting pressure to drive efficiency within GMP compliance constraints. Quality, regulatory support, and consulting are embedded across all projects.
Rentschler Biopharma is a contract development and manufacturing organization (CDMO) for biopharmaceuticals. They offer process development, GMP-regulated manufacturing, formulation work, cell line development, and regulatory support. In 2023, they contributed to nearly 25% of all FDA-approved biologics.
Rentschler Biopharma is headquartered in Laupheim, Baden-Württemberg, Germany. The company also operates a site in Milford, Massachusetts, USA, and hires across both countries.
The stack centers on SAP (ERP), Microsoft Azure (Data Factory, Synapse Analytics, Fabric), SQL, Python, and specialized instruments: LIMS, HPLC, FT-IR. Current projects include ETL pipeline development, data science/AI solutions, and modernization of GMP documentation systems.
Other companies in the same industry, closest in size